Deletion of microsomal prostaglandin E synthase-1 does not alter ozone-induced airway hyper-responsiveness

Journal of Pharmacology and Experimental Therapeutics

Volumn 334, Issue 1, 2010, Pages 63-68

  Wang, Miao ^a   Cooper, Philip R ^b   Jiang, Meiqi ^b   Zhao, Hengjiang ^b   Hui, Yiqun ^a   Yao, Yubing ^a   Tate, Joshua C ^b   Damera, Gautam ^b   Lawson, John A ^a   Jester Jr , William F ^b   Haczku, Angela ^b   Panettieri Jr , Reynold A ^b   FitzGerald, Garret A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHACHOLINE; OZONE; PROSTAGLANDIN D2; PROSTAGLANDIN E SYNTHASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MIGRATION; FEMALE; LUNG CLEARANCE; LUNG LAVAGE; LUNG RESISTANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE;

AIRWAY RESISTANCE; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARBACHOL; CELL DIFFERENTIATION; DINOPROSTONE; FEMALE; GENE DELETION; INTRAMOLECULAR OXIDOREDUCTASES; METHACHOLINE CHLORIDE; MICE; MICE, KNOCKOUT; MICROSOMES; MUSCLE CONTRACTION; MUSCLE, SMOOTH; OZONE; PROSTAGLANDINS; RESPIRATORY SYSTEM;

EID: 77953770999     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.110.166678     Document Type: Article

References (40)

1. Cheng Y, Wang M, Yu Y, Lawson J, Funk CD, and Fitzgerald GA (2006) Cyclooxygenases, microsomal prostaglandin E synthase-1, and cardiovascular function. J Clin Invest 116:1391-1399.
2. Coffey MJ, Wheeler CS, Gross KB, Eschenbacher WL, Sporn PH, and Peters-Golden M (1996) Increased 5-lipoxygenase metabolism in the lungs of human subjects exposed to ozone. Toxicology 114:187-197.
3. Cooper PR, Mesaros AC, Zhang J, Christmas P, Stark CM, Douaidy K, Mittelman MA, Soberman RJ, Blair IA, and Panettieri RA Jr (2010) 20-HETE mediates ozone-induced, neutrophil-independent airway hyper-responsiveness in mice. PLoS ONE, in press.
4. Cooper PR, Lamb R, Day ND, Branigan PJ, Kajekar R, San Mateo L, Hornby PJ, and Panettieri RA Jr (2009) TLR3 activation stimulates cytokine secretion without altering agonist-induced human small airway contraction or relaxation. Am J Physiol Lung Cell Mol Physiol 297:L530-L537.
5. Cooper PR and Panettieri RA Jr (2008) Steroids completely reverse albuterol-induced β(2)-adrenergic receptor tolerance in human small airways. J Allergy Clin Immunol 122:734-740.
6. Engblom D, Saha S, Engström L, Westman M, Audoly LP, Jakobsson PJ, and Blomqvist A (2003) Microsomal prostaglandin E synthase-1 is the central switch during immune-induced pyresis. Nat Neurosci 6:1137-1138.
7. FitzGerald GA (2007) COX-2 in play at the AHA and the FDA. Trends Pharmacol Sci 28:303-307.
8. Grosser T, Yu Y, and Fitzgerald GA (2010) Emotion recollected in tranquility: lessons learned from the COX-2 saga. Annu Rev Med 61:17-33.
9. Hammad H, Kool M, Soullié T, Narumiya S, Trottein F, Hoogsteden HC, and Lambrecht BN (2007) Activation of the D prostanoid 1 receptor suppresses asthma by modulation of lung dendritic cell function and induction of regulatory T cells. J Exp Med 204:357-367.
10. Holroyde MC and Norris AA (1988) The effect of ozone on reactivity of upper and lower airways in guinea pigs. Br J Pharmacol 94:938-946.
11. Honda T, Segi-Nishida E, Miyachi Y, and Narumiya S (2006) Prostacyclin-IP signaling and prostaglandin E2-EP2/EP4 signaling both mediate joint inflammation in mouse collagen-induced arthritis. J Exp Med 203:325-335.
12. Idzko M, Hammad H, van Nimwegen M, Kool M, Vos N, Hoogsteden HC, and Lambrecht BN (2007) Inhaled iloprost suppresses the cardinal features of asthma via inhibition of airway dendritic cell function. J Clin Invest 117:464-472.
13. Jaffar Z, Wan KS, and Roberts K (2002) A key role for prostaglandin I2 in limiting lung mucosal Th2, but not Th1, responses to inhaled allergen. J Immunol 169:5997-6004.
14. Jakobsson PJ, Thorén S, Morgenstern R, and Samuelsson B (1999) Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target. Proc Natl Acad Sci USA 96:7220-7225.
15. Kamei D, Yamakawa K, Takegoshi Y, Mikami-Nakanishi M, Nakatani Y, Oh-Ishi S, Yasui H, Azuma Y, Hirasawa N, Ohuchi K, et al. (2004) Reduced pain hypersensitivity and inflammation in mice lacking microsomal prostaglandin E synthase-1. J Biol Chem 279:33684-33695.
16. Kierstein S, Krytska K, Sharma S, Amrani Y, Salmon M, Panettieri RA Jr, Zangrilli J, and Haczku A (2008) Ozone inhalation induces exacerbation of eosinophilic airway inflammation and hyper-responsiveness in allergen-sensitized mice. Allergy 63:438-446.
17. Kierstein S, Poulain FR, Cao Y, Grous M, Mathias R, Kierstein G, Beers MF, Salmon M, Panettieri RA Jr, and Haczku A (2006) A susceptibility to ozone-induced airway inflammation is associated with decreased levels of surfactant protein D. Respir Res 7:85.
18. Mathé AA, Hedqvist P, Holmgren A, and Svanborg N (1973) Bronchial hyper-reactivity to prostaglandin F2 and histamine in patients with asthma. Br Med J 1:193-196.
19. Matsuoka T, Hirata M, Tanaka H, Takahashi Y, Murata T, Kabashima K, Sugimoto Y, Kobayashi T, Ushikubi F, Aze Y, et al. (2000) Prostaglandin D2 as a mediator of allergic asthma. Science 287:2013-2017.
20. Mbalaviele G, Pauley AM, Shaffer AF, Zweifel BS, Mathialagan S, Mnich SJ, Nemirovskiy OV, Carter J, Gierse JK, Wang JL, et al. (2010) Distinction of microsomal prostaglandin E synthase-1 (mPGES-1) inhibition from cyclooxygenase-2 inhibition in cells using a novel, selective mPGES-1 inhibitor. Biochem Pharmacol 79:1445-1454.
21. Murakami M and Kudo I (2006) Prostaglandin E synthase: a novel drug target for inflammation and cancer. Curr Pharm Des 12:943-954.
22. Murata T, Ushikubi F, Matsuoka T, Hirata M, Yamasaki A, Sugimoto Y, Ichikawa A, Aze Y, Tanaka T, Yoshida N, et al. (1997) Altered pain perception and inflammatory response in mice lacking prostacyclin receptor. Nature 388:678-682.
23. Nagao K, Tanaka H, Komai M, Masuda T, Narumiya S, and Nagai H (2003) Role of prostaglandin I2 in airway remodeling induced by repeated allergen challenge in mice. Am J Respir Cell Mol Biol 29:314-320.
24. Narumiya S, Sugimoto Y, and Ushikubi F (1999) Prostanoid receptors: structures, properties, and functions. Physiol Rev 79:1193-1226.
25. Oguma T, Asano K, and Ishizaka A (2008) Role of prostaglandin D(2) and its receptors in the pathophysiology of asthma. Allergol Int 57:307-312.
26. Pini B, Grosser T, Lawson JA, Price TS, Pack MA, and FitzGerald GA (2005) Prostaglandin E synthases in zebrafish. Arterioscler Thromb Vasc Biol 25:315-320.
27. Ressmeyer AR, Larsson AK, Vollmer E, Dahlèn SE, Uhlig S, and Martin C (2006) Characterisation of guinea pig precision-cut lung slices: comparison with human tissues. Eur Respir J 28:603-611.
28. Samuelsson B, Morgenstern R, and Jakobsson PJ (2007) Membrane prostaglandin E synthase-1: a novel therapeutic target. Pharmacol Rev 59:207-224.
29. Scholich K and Geisslinger G (2006) Is mPGES-1 a promising target for pain therapy? Trends Pharmacol Sci 27:399-401.
30. Seltzer J, Bigby BG, Stulbarg M, Holtzman MJ, Nadel JA, Ueki IF, Leikauf GD, Goetzl EJ, and Boushey HA (1986) O3-induced change in bronchial reactivity to methacholine and airway inflammation in humans. J Appl Physiol 60:1321-1326. (Pubitemid 16028433)
31. Sestini P, Armetti L, Gambaro G, Pieroni MG, Refini RM, Sala A, Vaghi A, Folco GC, Bianco S, and Robuschi M (1996) Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma. Am J Respir Crit Care Med 153:572-575.
32. Swedin L, Neimert-Andersson T, Hjoberg J, Jonasson S, van Hage M, Adner M, Ryrfeldt A, and Dahlén SE (2009) Dissociation of airway inflammation and hyper-responsiveness by cyclooxygenase inhibition in allergen challenged mice. Eur Respir J 34:200-208.
33. Takahashi Y, Tokuoka S, Masuda T, Hirano Y, Nagao M, Tanaka H, Inagaki N, Narumiya S, and Nagai H (2002) Augmentation of allergic inflammation in prostanoid IP receptor deficient mice. Br J Pharmacol 137:315-322.
34. Tanioka T, Nakatani Y, Semmyo N, Murakami M, and Kudo I (2000) Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2 biosynthesis. J Biol Chem 275:32775-32782.
35. Thorén S, Weinander R, Saha S, Jegerschöld C, Pettersson PL, Samuelsson B, Hebert H, Hamberg M, Morgenstern R, and Jakobsson PJ (2003) Human microsomal prostaglandin E synthase-1: purification, functional characterization, and projection structure determination. J Biol Chem 278:22199-22209.
36. Tilley SL, Hartney JM, Erikson CJ, Jania C, Nguyen M, Stock J, McNeisch J, Valancius C, Panettieri RA Jr, Penn RB, et al. (2003) Receptors and pathways mediating the effects of prostaglandin E2 on airway tone. Am J Physiol Lung Cell Mol Physiol 284:L599-L606. (Pubitemid 36343308)
37. Trebino CE, Stock JL, Gibbons CP, Naiman BM, Wachtmann TS, Umland JP, Pandher K, Lapointe JM, Saha S, Roach ML, et al. (2003) Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase. Proc Natl Acad Sci USA 100:9044-9049.
38. Wang M, Lee E, Song W, Ricciotti E, Rader DJ, Lawson JA, Puré E, and FitzGerald GA (2008) Microsomal prostaglandin E synthase-1 deletion suppresses oxidative stress and angiotensin II-induced abdominal aortic aneurysm formation. Circulation 117:1302-1309.
39. Wang M, Zukas AM, Hui Y, Ricciotti E, Puré E, and FitzGerald GA (2006) Deletion of microsomal prostaglandin E synthase-1 augments prostacyclin and retards atherogenesis. Proc Natl Acad Sci USA 103:14507-14512.
40. Xu D, Rowland SE, Clark P, Giroux A, Côté B, Guiral S, Salem M, Ducharme Y, Friesen RW, Méthot N, et al. (2008) MF63 [2-(6-chloro-1H-phenanthro[9,10-d]imidazol-2-yl)-isophthalonitrile], a selective microsomal prostaglandin E synthase-1 inhibitor, relieves pyresis and pain in preclinical models of inflammation. J Pharmacol Exp Ther 326:754-763.